Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/NEUROSENSE-THERAPEUTICS-L-130483704/attualita/NeuroSense-Therapeutics-Ltd-riceve-i-brevetti-in-Europa-Giappone-e-Israele-per-il-suo-farmaco-Prim-44888167/?utm_source=whatsapp&utm_medium=social&utm_campaign=share